BIOMAT Database Logo BIOMAT Database Logo

[Clinical and bacteriological evaluation of Amikin (Amikacin sulfate) by Bristol-Myers]. 1978

J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Evaluation of amikacin sulfate (Amikin). A new aminoglycoside antibiotic.
October 1977, JAMA,
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Technology evaluation: abatacept, Bristol-Myers Squibb.
June 2004, Current opinion in molecular therapeutics,
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Technology evaluation: Belatacept, Bristol-Myers Squibb.
August 2005, Current opinion in molecular therapeutics,
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Technology evaluation: ipilimumab, Medarex/Bristol-Myers Squibb.
December 2005, Current opinion in molecular therapeutics,
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Omapatrilat. Bristol-Myers Squibb.
October 2001, Current opinion in investigational drugs (London, England : 2000),
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Headache for Bristol-Myers.
November 1979, Science (New York, N.Y.),
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Entecavir (Bristol-Myers Squibb).
May 2001, Current opinion in investigational drugs (London, England : 2000),
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
[Bacteriological and clinical results of amikacin].
February 1980, Orvosi hetilap,
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Bristol Laboratories Division, Bristol-Myers Company, Syracuse, N.Y.
January 1978, Antibiotics and chemotherapy,
J Wencel, and M Czaplicki, and A Borkowski, and A W Malewski
Ravuconazole Eisai/Bristol-Myers Squibb.
April 2002, Current opinion in investigational drugs (London, England : 2000),
Copied contents to your clipboard!